- Home
- TAK vs EL Comparison
TAK vs EL Comparison
Compare TAK & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | EL |
|---|---|---|
| Founded | 1781 | 1946 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3B | 41.5B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | TAK | EL |
|---|---|---|
| Price | $18.55 | $112.16 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 22 |
| Target Price | N/A | ★ $103.05 |
| AVG Volume (30 Days) | 3.1M | ★ 4.5M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 2.83% | 1.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $14,326,000,000.00 |
| Revenue This Year | N/A | $7.66 |
| Revenue Next Year | $0.95 | $4.21 |
| P/E Ratio | ★ $41.25 | $196.46 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.99 | $48.37 |
| 52 Week High | $18.79 | $121.64 |
Technical Indicators
Market Signals| Indicator | TAK | EL |
|---|---|---|
| Relative Strength Index (RSI) | 76.26 | 55.63 |
| Support Level | $18.20 | $109.98 |
| Resistance Level | $18.79 | $113.84 |
| Average True Range (ATR) | 0.21 | 5.26 |
| MACD | 0.02 | 0.38 |
| Stochastic Oscillator | 88.72 | 74.13 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About EL Estee Lauder Companies Inc. (The)
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.